Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2013 2
2014 2
2016 3
2017 5
2018 4
2019 1
2020 4
2021 3
2022 4
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Characterization of Immunogenicity and Safety of COVID-19 mRNA-1273 in HIV-Positive Italian Patients with Hemophilia: A Prospective Single-Center Cohort Study.
Suffritti C, Gualtierotti R, Arcudi S, Ciavarella A, Novembrino C, Lecchi A, La Marca S, Padovan L, Scalambrino E, Clerici M, Bono P, Ceriotti F, Muscatello A, Siboni SM, Peyvandi F. Suffritti C, et al. J Clin Med. 2023 Aug 23;12(17):5475. doi: 10.3390/jcm12175475. J Clin Med. 2023. PMID: 37685542 Free PMC article.
Risk of relapse after SARS-CoV-2 vaccine in the Milan cohort of thrombotic thrombocytopenic purpura patients.
Capecchi M, De Leo P, Abbattista M, Mancini I, Agosti P, Biganzoli M, Suffritti C, Ferrari B, Lecchi A, La Marca S, Padovan L, Scalambrino E, Clerici M, Tripodi A, Artoni A, Gualtierotti R, Peyvandi F. Capecchi M, et al. Among authors: suffritti c. Haematologica. 2023 Nov 1;108(11):3152-3155. doi: 10.3324/haematol.2022.282478. Haematologica. 2023. PMID: 36951158 Free PMC article. No abstract available.
Updates on Novel Non-Replacement Drugs for Hemophilia.
Gualtierotti R, Pasca S, Ciavarella A, Arcudi S, Giachi A, Garagiola I, Suffritti C, Siboni SM, Peyvandi F. Gualtierotti R, et al. Among authors: suffritti c. Pharmaceuticals (Basel). 2022 Sep 23;15(10):1183. doi: 10.3390/ph15101183. Pharmaceuticals (Basel). 2022. PMID: 36297295 Free PMC article. Review.
Anti-C1-Inhibitor Autoantibody Detection by ELISA.
Suffritti C, Caccia S, Berra S, Parolin D, Cicardi M. Suffritti C, et al. Methods Mol Biol. 2021;2227:115-120. doi: 10.1007/978-1-0716-1016-9_11. Methods Mol Biol. 2021. PMID: 33847936
Hereditary angioedema due to C1 inhibitor deficiency in Belarus: epidemiology, access to diagnosis and seven novel mutations in SERPING1 gene.
Guryanova I, Suffritti C, Parolin D, Zanichelli A, Ishchanka N, Polyakova E, Belevtsev M, Perego F, Cicardi M, Zharankova Y, Konoplya N, Caccia S, Gidaro A. Guryanova I, et al. Among authors: suffritti c. Clin Mol Allergy. 2021 Apr 7;19(1):3. doi: 10.1186/s12948-021-00141-0. Clin Mol Allergy. 2021. PMID: 33827715 Free PMC article.
Decreasing Attacks and Improving Quality of Life through a Systematic Management Program for Patients with Hereditary Angioedema.
Nunes FL, Ferriani MPL, Moreno AS, Langer SS, Maia LSM, Ferraro MF, Sarti W, Bessa Junior J, Cunha D, Suffritti C, Dias MM, Januário YC, daSilva LLP, Aragon DC, Caballero T, Arruda LK. Nunes FL, et al. Among authors: suffritti c. Int Arch Allergy Immunol. 2021;182(8):697-708. doi: 10.1159/000513896. Epub 2021 Mar 3. Int Arch Allergy Immunol. 2021. PMID: 33657571
30 results